Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Galapagos 100 euro per aandeel

1.208 Posts
Pagina: «« 1 ... 34 35 36 37 38 ... 61 »» | Laatste | Omlaag ↓
  1. [verwijderd] 3 september 2017 22:59
    Recent IBD Deals

    1. Johnson & Johnson commits $990M to land Protagonist’s oral Crohn’s drug (preclinical)

    "Johnson & Johnson has landed rights to Protagonist Therapeutics’ preclinical Crohn’s disease asset PTG-200. The deal gives J&J a stake in an oral interleukin-23 (IL-23) receptor antagonist in return for $50 million upfront and up to $940 million in milestones."

    www.fiercebiotech.com/biotech/j-j-com...

    2. Celgene Completes Acquisition of Receptos, Advancing Leadership in Immune-Inflammatory Diseases

    "Celgene Corporation (CELG) today announced it has closed its acquisition of Receptos, Inc. Receptos stockholders received $232.00 per share in cash, for a total of approximately $7.2 billion, net of cash acquired."

    www.fiercepharma.com/pharma/celgene-c...

    3. Celgene enters deal potentially worth over $2.5 billion for Nogra Pharma's Crohn's disease drug

    "Celgene announced a global licensing deal Thursday potentially valued at more than $2.5 billion to develop and market Nogra Pharma's experimental drug GED-0301 for moderate-to-severe Crohn's disease and other indications."

    www.firstwordpharma.com/node/1205296?...

    4. Gilead swoops down on Galapagos JAK1 candidate filgotinib in $2.075B deal

    "Gilead Sciences Inc., is stepping in where Abbvie Inc. stepped out, laying down a whopping $725 million, with up to $1.35 billion more to come in milestones, for rights to Galapagos NV's Janus kinase 1 (JAK1)-selective inhibitor filgotinib (GLPG0634)."

    www.bioworld.com/content/gilead-swoop...

    5. Salix Expands in GI Drugs and Beyond with $2.6B Santarus Acquisition

    "Salix Pharmaceuticals said it will acquire Santarus for about $2.6 billion, in an all-cash deal that expands the buyer’s gastrointestinal (GI) drug portfolio and extends its product offerings into primary care and diabetes."

    www.genengnews.com/gen-news-highlight...

  2. [verwijderd] 5 september 2017 22:37
    quote:

    inspirator schreef op 5 september 2017 21:43:

    [...]

    Nog 5% bij koers en krak daar is koers Galapagos van 100 dollar
    De titel van het draadje is wel galapagos 100 EURO per aandeel, niet dollar.
  3. [verwijderd] 6 september 2017 19:55
    Galapagos NV (ADR) (GLPG) Hit All Time High
    September 6, 2017 - By Linda Rogers

    The stock of Galapagos NV (ADR) (NASDAQ:GLPG) reached all time high today, Sep, 6 and still has $103.62 target or 7.00 % above today’s $96.84 share price. This indicates more upside for the $4.87B company. This technical setup was reported by Barchart.com. If the $103.62 PT is reached, the company will be worth $340.90 million more.
    Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events.

    About 55,360 shares traded. Galapagos NV (ADR) (NASDAQ:GLPG) has risen 65.27% since September 6, 2016 and is uptrending. It has outperformed by 48.57% the S&P500.
  4. [verwijderd] 9 september 2017 10:21
    quote:

    inspirator schreef op 9 september 2017 08:55:

    Verwachte koersontwikkeling Galapagos intact.
    Zeker, één goed persbericht en we staan op €100!
  5. [verwijderd] 13 september 2017 18:40
    quote:

    inspirator schreef op 4 maart 2016 01:01:

    Overvolle pijplijn Galapagos met 1,2 miljard cash.

    Stijging koers Galapagos naar 100 euro in verschiet.
    De (snel)weg naar koersniveau Galapagos 100 euro.
1.208 Posts
Pagina: «« 1 ... 34 35 36 37 38 ... 61 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.017
AB InBev 2 5.496
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.649
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.645
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.751
Aedifica 3 916
Aegon 3.258 322.826
AFC Ajax 538 7.088
Affimed NV 2 6.296
ageas 5.844 109.892
Agfa-Gevaert 14 2.050
Ahold 3.538 74.335
Air France - KLM 1.025 35.043
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.796
Allfunds Group 4 1.473
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.161
AMG 971 133.325
AMS 3 73
Amsterdam Commodities 305 6.689
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 14.998
Apollo Alternative Assets 1 17
Apple 5 381
Arcadis 252 8.776
Arcelor Mittal 2.033 320.706
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.300
Aroundtown SA 1 219
Arrowhead Research 5 9.737
Ascencio 1 27
ASIT biotech 2 697
ASMI 4.108 39.096
ASML 1.766 107.171
ASR Nederland 21 4.484
ATAI Life Sciences 1 7
Atenor Group 1 491
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.667
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392

Macro & Bedrijfsagenda

  1. 24 februari

    1. Vastned Q4-cijfers
    2. PostNL Q4-cijfers
    3. Ifo ondernemersvertrouwen februari (Dld)
    4. Inflatie januari def. (eur)
    5. Chicago Fed index januari (VS)
    6. Retail Estates Q3-cijfers
    7. Vastned Belgium Q4-cijfers
    8. Zoom Video Communications Q4-cijfers (VS)
  2. 25 februari

    1. Ackermans & Van Haaren Q4-cijfers
    2. Economische groei vierde kwartaal def (Dld)
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht